ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells

Michele Dal Bo; Federico Pozzo; Riccardo Bomben; Massimo Degan; Daniela Marconi; Antonella Zucchetto; Davide Rossi; Gabriele Pozzato; Giorgio Zauli; Gianluca Gaidano; Giovanni Del Poeta; Valter Gattei

doi:10.1111/bjh.12258

ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells

Michele Dal Bo
, Federico Pozzo
, Riccardo Bomben
, Massimo Degan
, Daniela Marconi
, Antonella Zucchetto
, Davide Rossi
, Gabriele Pozzato
, Giorgio Zauli
, Gianluca Gaidano
, Giovanni Del Poeta
, Valter Gattei

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Lettera › peer review

Abstract

The gene expression signature associated with TP53 mutation/deletion in chronic lymphocytic leukaemia is dominated by the under-expression of TP53 and other genes on chromosome 17p.

Lingua originale	Inglese
pagine (da-a)	596-599
Numero di pagine	4
Rivista	British Journal of Haematology
Volume	161
Numero di pubblicazione	4
DOI	https://doi.org/10.1111/bjh.12258
Stato di pubblicazione	Pubblicato - mag 2013

Accesso al documento

10.1111/bjh.12258

Altri file e collegamenti

Link to publication in Scopus

Cita questo

Dal Bo, M., Pozzo, F., Bomben, R., Degan, M., Marconi, D., Zucchetto, A., Rossi, D., Pozzato, G., Zauli, G., Gaidano, G., Del Poeta, G., & Gattei, V. (2013). ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells. British Journal of Haematology, 161(4), 596-599. https://doi.org/10.1111/bjh.12258

@article{2d7a5d03cf0a4755b6df313c2d60542e,

title = "ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells",

abstract = "The gene expression signature associated with TP53 mutation/deletion in chronic lymphocytic leukaemia is dominated by the under-expression of TP53 and other genes on chromosome 17p.",

keywords = "CLL, Chemosensitivity, TP53",

author = "\{Dal Bo\}, Michele and Federico Pozzo and Riccardo Bomben and Massimo Degan and Daniela Marconi and Antonella Zucchetto and Davide Rossi and Gabriele Pozzato and Giorgio Zauli and Gianluca Gaidano and \{Del Poeta\}, Giovanni and Valter Gattei",

year = "2013",

month = may,

doi = "10.1111/bjh.12258",

language = "English",

volume = "161",

pages = "596--599",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

Dal Bo, M, Pozzo, F, Bomben, R, Degan, M, Marconi, D, Zucchetto, A, Rossi, D, Pozzato, G, Zauli, G, Gaidano, G, Del Poeta, G & Gattei, V 2013, 'ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells', British Journal of Haematology, vol. 161, n. 4, pagg. 596-599. https://doi.org/10.1111/bjh.12258

ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells. / Dal Bo, Michele; Pozzo, Federico; Bomben, Riccardo et al.
In: British Journal of Haematology, Vol. 161, N. 4, 05.2013, pag. 596-599.

Risultato della ricerca: Contributo su rivista › Lettera › peer review

TY - JOUR

T1 - ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells

AU - Dal Bo, Michele

AU - Pozzo, Federico

AU - Bomben, Riccardo

AU - Degan, Massimo

AU - Marconi, Daniela

AU - Zucchetto, Antonella

AU - Rossi, Davide

AU - Pozzato, Gabriele

AU - Zauli, Giorgio

AU - Gaidano, Gianluca

AU - Del Poeta, Giovanni

AU - Gattei, Valter

PY - 2013/5

Y1 - 2013/5

N2 - The gene expression signature associated with TP53 mutation/deletion in chronic lymphocytic leukaemia is dominated by the under-expression of TP53 and other genes on chromosome 17p.

AB - The gene expression signature associated with TP53 mutation/deletion in chronic lymphocytic leukaemia is dominated by the under-expression of TP53 and other genes on chromosome 17p.

KW - CLL

KW - Chemosensitivity

KW - TP53

UR - https://www.scopus.com/pages/publications/84876790162

U2 - 10.1111/bjh.12258

DO - 10.1111/bjh.12258

M3 - Letter

SN - 0007-1048

VL - 161

SP - 596

EP - 599

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 4

ER -

ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells

Abstract

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo